Skip to main content
. 2018 Jul 13;8:10606. doi: 10.1038/s41598-018-28854-4

Table 3.

Performance of predictors of NASH and advanced fibrosis assessed by ROC curve analysis.

SAF-Activity ≥2 NAS ≥5 Fibrosis >2
miR-34a/197 miR-192/197 AST miR-192/30c miR-27b/30c AST miR-27b/197 miR-27b/30c FIB-4
AUC 0.81
(0.72–0.90)*
0.78
(0.69–0.88)
0.75
(0.65–0.85)
0.78
(0.69–0.88)
0.79
(0.69–0.88)
0.75
(0.64–0.85)
0.75
(0.65–0.86)
0.77
(0.67–0.87)
0.85
(0.76–0.93)
Optimal cut-off 4.43 2.55 33 1.62 2.83 33 2.28 2.34 1.68
Sensitivity 0.73
(0.58–0.85)
0.74
(0.60–0.85)
0.74
(0.59–0.85)
0.87
(0.72–0.96)
0.55
(0.38–0.71)
0.79
(0.63–0.90)
0.83
(0.64–0.94)
0.72
(0.53–0.87)
0.72
(0.53–0.87)
Specificity 0.83
(0.67–0.93)
0.79
(0.63–0.90)
0.64
(0.48–0.78)
0.69
(0.54–0.80)
0.89
(0.77–0.96)
0.59
(0.45–0.73)
0.60
(0.47–0.72)
0.74
(0.62–0.85)
0.86
(0.75–0.93)
PPV (precision) 0.83
(0.69–0.91)
0.80
(0.66–0.90)
0.71
(0.56–0.84)
0.66
(0.52–0.86)
0.78
(0.60–0.88)
0.58
(0.43–0.76)
0.49
(0.36–0.76)
0.57
(0.42–0.77)
0.70
(0.53–0.86)
NPV 0.72
(0.57–0.87)
0.72
(0.57–0.86)
0.67
(0.52–0.81)
0.88
(0.74–0.93)
0.74
(0.59–0.89)
0.80
(0.64–0.88)
0.88
(0.74–0.93)
0.86
(0.71–0.91)
0.87
(0.74–0.94)
PLR 4.17
(2.08–8.35)
3.45
(1.89–6.31)
2.07
(1.34–3.21)
2.76
(1.83–4.17)
4.97
(2.22–11.2)
1.92
(1.35–2.78)
2.09
(1.47–2.95)
2.85
(1.77–4.60)
5.07
(2.63–9.66)
NLR 0.33
(0.20–0.53)
0.33
(0.20–0.54)
0.40
(0.24–0.68)
0.19
(0.08–0.44)
0.50
(0.35–0.73)
0.35
(0.19–0.68)
0.29
(0.13–0.65)
0.37
(0.20–0.68)
0.32
(0.18–0.59)
Accuracy 0.77
(0.67–0.85)
0.74
(0.64–0.83)
0.70
(0.59–0.79)
0.74
(0.64–0.82)
0.73
(0.63–0.82)
0.67
(0.57–0.77)
0.66
(0.56–0.76)
0.71
(0.61–0.81)
0.82
(0.72–0.89)

*Values within parenthesis indicate confidence intervals.

AUROC, area under the curve of the receiver operating characteristic; PPV, positive predictive value; NPV, negative predictive value; PLR, positive likelihood rate; NLR, negative likelihood ratio.